nach oben

European Child & Adolescent Psychiatry

Erschienen in:

28.06.2020 | Original Contribution

Efficacy and acceptability of a second dose of ecological executive skills training for children with ADHD: a randomized controlled study and follow-up

verfasst von: Ying Qian, Zili Fan, Bingling Gao, Sibley Margaret, Qingjiu Cao, Fei Li, Li Yang

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

To explore the efficacy and acceptability of a second dose of the 12-session ecological executive skills training (EEST) 1 year after the initial training in children with ADHD. A total of 97 children (aged 6–12) with ADHD who finished the first dose for about 1 year were recruited in the current study. 70 children who agreed to participate the second dose were randomized to the second dose or waitlist group. Both groups were followed up 1 year after the second dose. Executive function, core symptoms were assessed at the time of pre-intervention first dose, pre-intervention second dose, post-intervention second dose and follow-up 1 year after second dose (phase 0–3). For the immediate efficacy, the improvements in the second dose group were greater than the waitlist group on planning by Stockings of Cambridge and delay aversion by Cambridge gambling task (P = 0.02–0.04, η² = 0.07–0.08). The parent rating of symptoms assessed by ADHD-RS-IV of the second dose group were also greater than the waitlist group rated by self-report. For long term efficacy, Linear mixed model indicated that there was significant time effect for both groups between phase 3 and phase 1, phase 1 and phase 0 on Behavior Rating Scales of Executive Function and ADHD-RS-IV (F = 2.849–21.560, P = 0.001–0.048). The compliance rate was 94.3% for the second dose group and 49% for waitlist group. A second dose of EEST program might bring further efficacy of EF and core symptoms for children with ADHD and it was well accepted.

Thomas R, Sanders S, Doust J, Beller E, Glasziou P (2015) Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135(4):e994–e1001. https://doi.org/10.1542/peds.2014-3482CrossRefPubMed

van Lieshout M, Luman M, Twisk JW, van Ewijk H, Groenman AP, Thissen AJ, Faraone SV, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Franke B, Buitelaar JK, Rommelse NN, Oosterlaan J (2016) A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood. Eur Child Adolesc Psychiatry 25(9):1007–1017. https://doi.org/10.1007/s00787-016-0820-yCrossRefPubMedPubMedCentral

McGough JJ, Biederman J, Wigal SB, Lopez FA, McCracken JT, Spencer T, Zhang Y, Tulloch SJ (2005) Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry 44(6):530–538. https://doi.org/10.1097/01.chi.0000157550.94702.a2CrossRefPubMed

Serrano-Troncoso E, Guidi M, Alda-Diez JA (2013) Is psychological treatment efficacious for attention deficit hyperactivity disorder (ADHD)? Review of non-pharmacological treatments in children and adolescents with ADHD. Actas espanolas de psiquiatria 41(1):44–51PubMed

Cortese S, Ferrin M, Brandeis D, Buitelaar J, Daley D, Dittmann RW, Holtmann M, Santosh P, Stevenson J, Stringaris A, Zuddas A, Sonuga-Barke EJ (2015) Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry 54(3):164–174. https://doi.org/10.1016/j.jaac.2014.12.010CrossRefPubMedPubMedCentral

Fowler PJ, Henry DB, Schoeny M, Gorman-Smith D, Tolan PH (2014) Effects of the SAFE Children preventive intervention on developmental trajectories of attention-deficit/hyperactivity disorder symptoms. Dev Psychopathol 26(4 Pt 1):1161–1179. https://doi.org/10.1017/S0954579414000170CrossRefPubMed

Pfiffner LJ, Rooney ME, Jiang YY, Haack LM, Beaulieu A, McBurnett K (2018) Sustained effects of collaborative school-home intervention for attention-deficit/hyperactivity disorder symptoms and impairment. J Am Acad Child Adolesc Psychiatry 57(4):245–251. https://doi.org/10.1016/j.jaac.2018.01.016CrossRefPubMed

Lim CG, Lee TS, Guan C, Fung DS, Zhao Y, Teng SS, Zhang H, Krishnan KR (2012) A brain-computer interface based attention training program for treating attention deficit hyperactivity disorder. PLoS One 7(10):e46692. https://doi.org/10.1371/journal.pone.0046692CrossRefPubMedPubMedCentral

Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L (2016) A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treatm 12:1191–1202. https://doi.org/10.2147/ndt.S104620CrossRef

10.

Klingberg T (2010) Training and plasticity of working memory. Trends Cogn Sci 14(7):317–324. https://doi.org/10.1016/j.tics.2010.05.002CrossRefPubMed

11.

Rapport MD, Orban SA, Kofler MJ, Friedman LM (2013) Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes. Clin Psychol Rev 33(8):1237–1252. https://doi.org/10.1016/j.cpr.2013.08.005CrossRefPubMed

12.

Tamm L, Nakonezny PA, Hughes CW (2014) An open trial of a metacognitive executive function training for young children with ADHD. J Atten Disord 18(6):551–559. https://doi.org/10.1177/1087054712445782CrossRefPubMed

13.

Qian Y, Chen M, Shuai L, Cao QJ, Yang L, Wang YF (2017) Effect of an ecological executive skill training program for school-aged children with attention deficit hyperactivity disorder: a randomized controlled clinical trial. Chin Med J (Engl) 130(13):1513–1520. https://doi.org/10.4103/0366-6999.208236CrossRef

14.

Shuai L, Daley D, Wang YF, Zhang JS, Kong YT, Tan X, Ji N (2017) Executive function training for children with attention deficit hyperactivity disorder. Chin Med J (Engl) 130(5):549–558. https://doi.org/10.4103/0366-6999.200541CrossRef

15.

Diamond A, Ling DS (2016) Conclusions about interventions, programs, and approaches for improving executive functions that appear justified and those that, despite much hype, do not. Dev Cogn Neurosci 18:34–48. https://doi.org/10.1016/j.dcn.2015.11.005CrossRefPubMed

16.

Boyer BE, Geurts HM, Prins PJ, Van der Oord S (2016) One-year follow-up of two novel CBTs for adolescents with ADHD. Eur Child Adolesc Psychiatry 25(3):333–337. https://doi.org/10.1007/s00787-015-0776-3CrossRefPubMed

17.

Taylor SJ, Barker LA, Heavey L, McHale S (2015) The longitudinal development of social and executive functions in late adolescence and early adulthood. Front Behav Neurosci 9:252. https://doi.org/10.3389/fnbeh.2015.00252CrossRefPubMedPubMedCentral

18.

Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121(1):65–94. https://doi.org/10.1037/0033-2909.121.1.65CrossRefPubMed

19.

Gau SS, Shang CY (2010) Executive functions as endophenotypes in ADHD: evidence from the Cambridge Neuropsychological Test Battery (CANTAB). J Child Psychol Psychiatry 51(7):838–849. https://doi.org/10.1111/j.1469-7610.2010.02215.xCrossRefPubMed

20.

DeVito EE, Blackwell AD, Fau-Kent L, Ersche KD, Clark L, Salmond CH, Dezsery AM, Sahakian BJ (2008) The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol Psychiatry 64(7):636–639. https://doi.org/10.1016/j.biopsych.2008.04.017CrossRefPubMedPubMedCentral

21.

Coghill DR, Banaschewski T, Bliss C, Robertson B, Zuddas A (2018) Cognitive function of children and adolescents with attention-deficit/hyperactivity disorder in a 2-year open-label study of lisdexamfetamine dimesylate. CNS Drugs 32(1):85–95. https://doi.org/10.1007/s40263-017-0487-zCrossRefPubMedPubMedCentral

22.

Gioia GA, Isquith PK, Kenworthy L, Barton RM (2002) Profiles of everyday executive function in acquired and developmental disorders. Child Neuropsychol 8(2):121–137. https://doi.org/10.1076/chin.8.2.121.8727CrossRefPubMed

23.

Qian Y, Wang YF (2007) Reliability and validity of behavior rating scale of executive function parent form for school age children in China. Beijing Da Xue Xue Bao Yi Xue Ban 39(3):277–283PubMed

24.

Su LY, Geng YG, Wang H, Du YS, Zhao LS, Fan F (2006) Norm of ADHD diagnostic scale-parent version in chinese urban children. Chin J Pract Pediatr 11:833–836. https://doi.org/10.3969/j.issn.1005-2224.2006.11.013CrossRef

25.

Qian Y, Du QX, Qu S, Wang YF (2011) Reliability and validity of the Chinese version of Weiss functional impairment scale-parent form for school age children. Chin Mental Health J 25(10):767–771. https://doi.org/10.1007/s12264-011-1035-3CrossRef

26.

Sonuga-Barke EJS (2003) The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 27(7):593–604. https://doi.org/10.1016/j.neubiorev.2003.08.005CrossRefPubMed

27.

Dittner AJ, Hodsoll J, Rimes KA, Russell AJ, Chalder T (2018) Cognitive-behavioural therapy for adult attention-deficit hyperactivity disorder: a proof of concept randomised controlled trial. Acta Psychiatr Scand 137(2):125–137. https://doi.org/10.1111/acps.12836CrossRefPubMed

28.

Titz C, Karbach J (2014) Working memory and executive functions: effects of training on academic achievement. Psychol Res 78(6):852–868. https://doi.org/10.1007/s00426-013-0537-1CrossRefPubMed

29.

Bennett SJ, Holmes J, Buckley S (2013) Computerized memory training leads to sustained improvement in visuospatial short-term memory skills in children with down syndrome. Am J Intellect Dev Disabil 118(3):179–192. https://doi.org/10.1352/1944-7558-118.3.179CrossRefPubMed

30.

Qian Y, Shuai L, Chan RC, Qian QJ, Wang Y (2013) The developmental trajectories of executive function of children and adolescents with attention deficit hyperactivity disorder. Res Dev Disabil 34(5):1434–1445. https://doi.org/10.1016/j.ridd.2013.01.033CrossRefPubMed

31.

Evans SW, Owens JS, Bunford N (2014) Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol 43(4):527–551. https://doi.org/10.1080/15374416.2013.850700CrossRefPubMed

32.

Horigian VE, Anderson AR, Szapocznik J (2016) Family-based treatments for adolescent substance use. Child Adolesc Psychiatr Clin N Am 25(4):603–628. https://doi.org/10.1016/j.chc.2016.06.001CrossRefPubMedPubMedCentral

Titel: Efficacy and acceptability of a second dose of ecological executive skills training for children with ADHD: a randomized controlled study and follow-up
verfasst von: Ying Qian
Zili Fan
Bingling Gao
Sibley Margaret
Qingjiu Cao
Fei Li
Li Yang
Publikationsdatum: 28.06.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 6/2021
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-020-01571-y

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2021

Schizotypy and psychopathic tendencies interactively improve misattribution of affect in boys with conduct problems

Predictors of community versus specialty mental health service use: a prospective cohort study

ESCAP practice guidance for autism: a summary of evidence-based recommendations for diagnosis and treatment

Indicated prevention interventions for anxiety in children and adolescents: a review and meta-analysis of school-based programs